DMAA
Drugs Made In America Acquisition Corp. Rights
NASDAQ: DMAAR · ·
$0.09
-3.78% today
Updated 2026-04-29
Market cap
$1.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$—
Dividend yield
—
52W range
$0 – $0
Volume
0.2M
Drugs Made In America Acquisition Corp. Rights (DMAAR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item |
|---|
| Operating cash flow |
| Capital expenditures |
| Depreciation |
| Stock-based comp |
| Free cash flow |
| Investing cash flow |
| Financing cash flow |
| Dividends paid |
| Share repurchases |
| Debt repayment |
| Net change in cash |